Richard Moreau

Q: What Schools Are Affiliated With Richard Moreau

Richard Moreau is affiliated with the following schools: University of California, Berkeley, Université Paris Cité, University College London, Stanford University, Paris Diderot University

Richard Moreau's AcademicInfluence.com Rankings

Richard Moreau

Computer Science

#5271

World Rank

#5568

Historical Rank

Machine Learning

#1330

World Rank

#1351

Historical Rank

Artificial Intelligence

#1568

World Rank

#1598

Historical Rank

Database

#2428

World Rank

#2545

Historical Rank

computer-science Degrees

Download Badge

Computer Science

Richard Moreau's Degrees

PhD Computer Science Stanford University
Masters Computer Science University of California, Berkeley
Bachelors Computer Science University of California, Berkeley

Similar Degrees You Can Earn

Why Is Richard Moreau Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Richard Moreau's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. (2013) (2069)
The management of ascites in cirrhosis: Report on the consensus conference of the international Ascites club (2003) (826)
Acute-on chronic liver failure. (2012) (765)
Bacterial infections in cirrhosis: a position statement based on the EASL Special Conference 2013. (2014) (723)
Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites. (2015) (672)
Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure. (2014) (617)
Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) 2014 (2009) (541)
Liver sinusoidal endothelial cells: Physiology and role in liver diseases. (2017) (526)
Deleterious effects of beta‐blockers on survival in patients with cirrhosis and refractory ascites (2010) (482)
Systemic inflammation in decompensated cirrhosis: Characterization and role in acute‐on‐chronic liver failure (2016) (455)
Clinical Course of acute‐on‐chronic liver failure syndrome and effects on prognosis (2015) (455)
Severe sepsis in cirrhosis (2009) (419)
Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: a retrospective multicenter study. (2002) (414)
Acute-on-chronic liver failure: an update (2017) (401)
Mechanisms of decompensation and organ failure in cirrhosis: From peripheral arterial vasodilation to systemic inflammation hypothesis. (2015) (398)
Transjugular intrahepatic portosystemic shunts: Comparison with paracentesis in patients with cirrhosis and refractory ascites: A randomized trial (1996) (387)
Sepsis in cirrhosis: report on the 7th meeting of the International Ascites Club (2005) (379)
Autophagy in liver diseases. (2010) (375)
Working Party proposal for a revised classification system of renal dysfunction in patients with cirrhosis (2011) (370)
Acute-on-chronic liver failure: A new syndrome that will re-classify cirrhosis. (2015) (323)
Diagnosis of portopulmonary hypertension in candidates for liver transplantation: A prospective study (2003) (299)
Prognostic value of muscle atrophy in cirrhosis using psoas muscle thickness on computed tomography. (2014) (295)
Identification of Restricted Subsets of Mature microRNA Abnormally Expressed in Inactive Colonic Mucosa of Patients with Inflammatory Bowel Disease (2010) (264)
Acute-on-chronic liver failure in cirrhosis (2016) (258)
Acute renal failure in patients with cirrhosis: Perspectives in the age of MELD (2003) (257)
The CLIF Consortium Acute Decompensation score (CLIF-C ADs) for prognosis of hospitalised cirrhotic patients without acute-on-chronic liver failure. (2015) (251)
Model for end‐stage liver disease score and systemic inflammatory response are major prognostic factors in patients with cirrhosis and acute functional renal failure (2007) (240)
Epidemiology and Effects of Bacterial Infections in Patients With Cirrhosis Worldwide. (2019) (237)
Management of the critically ill patient with cirrhosis: A multidisciplinary perspective. (2016) (231)
Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites (2015) (223)
The evaluation of renal function and disease in patients with cirrhosis. (2010) (222)
Central role of mitochondria in drug-induced liver injury (2012) (211)
Cirrhotic patients in the medical intensive care unit: Early prognosis and long-term survival* (2010) (205)
Portal cavernoma‐associated cholangiopathy: A clinical and MR cholangiography coupled with MR portography imaging study (2003) (204)
Cardiac hepatopathy: Clinical, hemodynamic, and histologic characteristics and correlations (2003) (195)
Beneficial effects of the 2‐day administration of terlipressin in patients with cirrhosis and hepatorenal syndrome (1998) (183)
Beta-blockers cause paracentesis-induced circulatory dysfunction in patients with cirrhosis and refractory ascites: a cross-over study. (2011) (182)
Treatment with non-selective beta blockers is associated with reduced severity of systemic inflammation and improved survival of patients with acute-on-chronic liver failure. (2016) (182)
Role of nitric oxide in hepatopulmonary syndrome in cirrhotic rats. (2001) (179)
Prevention of gram-negative translocation reduces the severity of hepatopulmonary syndrome. (2002) (176)
Acute liver cell damage in patients with anorexia nervosa: a possible role of starvation-induced hepatocyte autophagy. (2008) (173)
Refractory ascites: pathogenesis, definition and therapy of a severe complication in patients with cirrhosis (2010) (169)
10-Fold increase (2006-11) in the rate of healthy subjects with extended-spectrum β-lactamase-producing Escherichia coli faecal carriage in a Parisian check-up centre. (2013) (165)
NADPH Oxidase 1 Modulates WNT and NOTCH1 Signaling To Control the Fate of Proliferative Progenitor Cells in the Colon (2010) (164)
Inaccuracies of creatinine and creatinine‐based equations in candidates for liver transplantation with low creatinine: Impact on the model for end‐stage liver disease score (2010) (157)
Diagnostic accuracy of the Multistix 8 SG reagent strip in diagnosis of spontaneous bacterial peritonitis (2007) (156)
The spectrum of renal lesions in patients with cirrhosis: a clinicopathological study (2010) (154)
Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF. (2019) (152)
The PREDICT study uncovers three clinical courses in acutely decompensated cirrhosis with distinct pathophysiology (120/120). (2020) (146)
The emerging roles of microvesicles in liver diseases (2014) (145)
Septic shock in patients with cirrhosis: Hemodynamic and metabolic characteristics and intensive care unit outcome (1992) (144)
The use of vasoconstrictors in patients with cirrhosis: Type 1 HRS and beyond (2006) (142)
Diabetes mellitus is an independent prognostic factor for major liver‐related outcomes in patients with cirrhosis and chronic hepatitis C (2014) (141)
Comparison of the effect of terlipressin and albumin on arterial blood volume in patients with cirrhosis and tense ascites treated by paracentesis: a randomised pilot study (2002) (140)
Persistence of systemic and splanchnic hyperkinetic circulation in liver transplant patients (1993) (139)
Coagulation disorders in patients with cirrhosis and severe sepsis (2003) (139)
Pentoxifylline does not decrease short-term mortality but does reduce complications in patients with advanced cirrhosis. (2010) (137)
Noninvasive assessment of portal hypertension in patients with cirrhosis (2011) (135)
Clinical course, predictive factors and prognosis in patients with cirrhosis and type 1 hepatorenal syndrome treated with Terlipressin: A retrospective analysis (2002) (134)
Albumin in decompensated cirrhosis: new concepts and perspectives (2020) (130)
Effects of Albumin Treatment on Systemic and Portal Hemodynamics and Systemic Inflammation in Patients With Decompensated Cirrhosis. (2019) (129)
Clinical characteristics and outcome of patients with cirrhosis and refractory ascites (2004) (127)
NOX family NADPH oxidases in liver and in pancreatic islets: a role in the metabolic syndrome and diabetes? (2008) (127)
Mucosal-associated invariant T cells are a profibrogenic immune cell population in the liver (2018) (125)
Transjugular intrahepatic portosystemic shunt in refractory ascites: a meta‐analysis (2005) (125)
Gene expression and hepatitis C virus infection (2008) (122)
Liver failure determines the outcome in patients of acute-on-chronic liver failure (ACLF): comparison of APASL ACLF research consortium (AARC) and CLIF-SOFA models (2017) (122)
Characteristics, Diagnosis and Prognosis of Acute-on-Chronic Liver Failure in Cirrhosis Associated to Hepatitis B. (2016) (121)
Acute-on-Chronic Liver Failure. (2020) (119)
In vivo hepatic endoplasmic reticulum stress in patients with chronic hepatitis C (2010) (118)
Diabetes mellitus in patients with cirrhosis: clinical implications and management (2016) (118)
Impact of COVID-19 on the care of patients with liver disease: EASL-ESCMID position paper after 6 months of the pandemic (2020) (116)
The Systemic Inflammation Hypothesis: Towards a New Paradigm of Acute Decompensation and Multiorgan Failure in Cirrhosis. (2020) (114)
Abnormal tissue oxygenation in patients with cirrhosis and liver failure. (1988) (112)
PNPLA3 rs738409, hepatocellular carcinoma occurrence and risk model prediction in patients with cirrhosis. (2013) (110)
Microbial epidemiology and outcome of bloodstream infections in liver transplant recipients: An analysis of 259 episodes (2010) (105)
Neutrophil gelatinase-associated lipocalin is a biomarker of acute-on-chronic liver failure and prognosis in cirrhosis. (2016) (103)
Transjugular intrahepatic portosystemic shunts: comparison with paracentesis in patients with cirrhosis and refractory ascites: a randomized trial. French Group of Clinicians and a Group of Biologists. (1996) (103)
Beneficial hemodynamic effects of bosentan, a mixed ETA and ETB receptor antagonist, in portal hypertensive rats (1998) (102)
Comparison of outcome in patients with cirrhosis and ascites following treatment with albumin or a synthetic colloid: (2006) (102)
Abnormal plasma microparticles impair vasoconstrictor responses in patients with cirrhosis. (2012) (102)
Effects of Long-term Norfloxacin Therapy in Patients With Advanced Cirrhosis. (2018) (100)
Glomerular filtration rate equations for liver‐kidney transplantation in patients with cirrhosis: Validation of current recommendations (2014) (98)
PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis. (2020) (98)
Addressing Profiles of Systemic Inflammation Across the Different Clinical Phenotypes of Acutely Decompensated Cirrhosis (2019) (98)
Upregulation of TNF-alpha production signaling pathways in monocytes from patients with advanced cirrhosis: possible role of Akt and IRAK-M. (2006) (97)
Hemodynamic effects of a clonidine‐induced decrease in sympathetic tone in patients with cirrhosis (1987) (95)
Inflammation and portal hypertension - the undiscovered country. (2014) (93)
Postprandial hemodynamic responses in patients with cirrhosis (1988) (92)
The role of nitric oxide in the hyperdynamic circulatory syndrome associated with portal hypertension. (1995) (90)
Increased renal expression and urinary excretion of TLR4 in acute kidney injury associated with cirrhosis (2013) (90)
Altered endoplasmic reticulum stress affects translation in inactive colon tissue from patients with ulcerative colitis. (2011) (89)
Role of prostacyclin in hemodynamic alterations in conscious rats with extrahepatic or intrahepatic portal hypertension (1993) (88)
Hypoxemia in patients with cirrhosis: relationship with liver failure and hemodynamic alterations. (1997) (88)
Endogenous factors involved in the control of arterial tone in cirrhosis. (1995) (85)
The Acute-on-Chronic Liver Failure Syndrome, or When the Innate Immune System Goes Astray (2016) (84)
Relationship between the Fibrotest and portal hypertension in patients with liver disease (2007) (83)
Vascular hyporesponsiveness to endothelin 1 in rats with cirrhosis. (1994) (83)
Prevalence and short-term mortality of acute-on-chronic liver failure: A national cohort study from the USA. (2019) (81)
Prevalence of day-care centre children (France) with faecal CTX-M-producing Escherichia coli comprising O25b:H4 and O16:H5 ST131 strains. (2014) (80)
Autophagy: A Multifaceted Partner in Liver Fibrosis (2014) (80)
Endogenous pulmonary nitric oxide production measured from exhaled air is increased in patients with severe cirrhosis. (1995) (80)
Pretransplant Fecal Carriage of Extended-Spectrum β-Lactamase–producing Enterobacteriaceae and Infection after Liver Transplant, France (2012) (79)
Role of aortic nitric oxide synthase 3 (eNOS) in the systemic vasodilation of portal hypertension. (2000) (76)
Norfloxacin reduces aortic NO synthases and proinflammatory cytokine up-regulation in cirrhotic rats: role of Akt signaling. (2005) (76)
Genetic Diversity and Virulence Profiles of Escherichia coli Isolates Causing Spontaneous Bacterial Peritonitis and Bacteremia in Patients with Cirrhosis (2010) (76)
Evidence for normal nitric oxide—mediated vasodilator tone in conscious rats with cirrhosis (1992) (76)
Sepsis in alcohol-related liver disease. (2017) (76)
Acute‐on‐Chronic Liver Failure: Getting Ready for Prime Time? (2018) (75)
Role of shear stress in aortic eNOS up-regulation in rats with biliary cirrhosis. (2002) (74)
Terlipressin inhibits in vivo aortic iNOS expression induced by lipopolysaccharide in rats with biliary cirrhosis (2002) (73)
Model for end‐stage liver disease exceptions in the context of the french model for end‐stage liver disease score–based liver allocation system (2011) (73)
The Pathogenesis of ACLF: The Inflammatory Response and Immune Function (2016) (71)
Elevated circulating cardiac troponin I in patients with cirrhosis (1999) (69)
Gene- and exon-expression profiling reveals an extensive LPS-induced response in immune cells in patients with cirrhosis. (2013) (69)
Both IgA nephropathy and alcoholic cirrhosis feature abnormally glycosylated IgA1 and soluble CD89-IgA and IgG-IgA complexes: common mechanisms for distinct diseases. (2011) (68)
Effects of lipopolysaccharide on TNF-alpha production, hepatic NOS2 activity, and hepatic toxicity in rats with cirrhosis. (2000) (67)
Ex vivo effects of high‐density lipoprotein exposure on the lipopolysaccharide‐induced inflammatory response in patients with severe cirrhosis (2009) (66)
Bleeding in patients with Budd-Chiari syndrome. (2011) (66)
High‐density lipoprotein administration attenuates liver proinflammatory response, restores liver endothelial nitric oxide synthase activity, and lowers portal pressure in cirrhotic rats (2007) (64)
Plasma cystatin C is a predictor of renal dysfunction, acute‐on‐chronic liver failure, and mortality in patients with acutely decompensated liver cirrhosis (2017) (64)
Total effective vascular compliance in patients with cirrhosis: A study of the response to acute blood volume expansion (1992) (64)
Beneficial hemodynamic effects of ketanserin in patients with cirrhosis: Possible role of serotonergic mechanisms in portal hypertension (1987) (63)
Hemodynamics after orthotopic liver transplantation: Study of associated factors and long‐term effects (1995) (63)
Orchestration of Tryptophan‐Kynurenine Pathway, Acute Decompensation, and Acute‐on‐Chronic Liver Failure in Cirrhosis (2019) (62)
Changes in autophagic response in patients with chronic hepatitis C virus infection. (2011) (62)
Acute-on-chronic liver failure: a new clinical entity. (2015) (62)
Efficacy of Albumin Treatment for Patients with Cirrhosis and Infections Unrelated to Spontaneous Bacterial Peritonitis. (2020) (62)
Hepatorenal syndrome in patients with cirrhosis (2002) (61)
Severe hyponatremia is a better predictor of mortality than MELDNa in patients with cirrhosis and refractory ascites. (2012) (60)
Acute-on-chronic liver failure: Definitions, pathophysiology and principles of treatment (2020) (59)
Hepatic Mitochondrial DNA Depletion after an Alcohol Binge in Mice: Probable Role of Peroxynitrite and Modulation by Manganese Superoxide Dismutase (2010) (59)
Comparison of two simplified severity scores (SAPS and APACHE II) for patients with acute myocardial infarction. (1989) (57)
Lipopolysaccharide-induced mitochondrial DNA depletion. (2011) (57)
Diagnosis and treatment of acute renal failure in patients with cirrhosis. (2007) (57)
In vivo altered unfolded protein response and apoptosis in livers from lipopolysaccharide-challenged cirrhotic rats. (2007) (56)
In Vitro Selection of ramR and soxR Mutants Overexpressing Efflux Systems by Fluoroquinolones as Well as Cefoxitin in Klebsiella pneumoniae (2011) (56)
Endothelial calcium-calmodulin dependent nitric oxide synthase in the in vitro vascular hyporeactivity of portal hypertensive rats. (1997) (55)
The diagnostic value of biomarkers (AshTest) for the prediction of alcoholic steato-hepatitis in patients with chronic alcoholic liver disease. (2006) (55)
Glycogen synthase kinase 3 involvement in the excessive proinflammatory response to LPS in patients with decompensated cirrhosis. (2011) (54)
Bacterial infection in compensated viral cirrhosis impairs 5-year survival (ANRS CO12 CirVir prospective cohort) (2015) (53)
Membrane Efflux and Influx Modulate both Multidrug Resistance and Virulence of Klebsiella pneumoniae in a Caenorhabditis elegans Model (2010) (52)
Nosocomial and Community-Acquired Spontaneous Bacterial Peritonitis: Comparative Microbiology and Therapeutic Implications (2003) (52)
Elevated circulating cardiac troponin I in patients with cirrhosis. (1999) (51)
Hyporeactivity of mesenteric resistance arteries in portal hypertensive rats. (1996) (50)
Combination of ketanserin and verapamil or propranolol in patients with alcoholic cirrhosis: Search for an additive effect (1989) (49)
Relationship between oxygen transport and oxygen uptake in patients with cirrhosis: Effects of vasoactive drugs (1989) (48)
Altered Control of Vascular Tone by Adenosine Triphosphate- Sensitive Potassium Channels in Rats With Cirrhosis (1994) (46)
Regional sympathetic activity, severity of liver disease and hemodynamics in patients with cirrhosis. (1991) (45)
HDL-related biomarkers are robust predictors of survival in patients with chronic liver failure. (2020) (45)
Impaired intracellular signaling, myeloperoxidase release and bactericidal activity of neutrophils from patients with alcoholic cirrhosis. (2016) (45)
Natriuretic response to the combination of atrial natriuretic peptide and terlipressin in patients with cirrhosis and refractory ascites. (1997) (45)
Inhibition of monoacylglycerol lipase, an anti-inflammatory and antifibrogenic strategy in the liver (2018) (44)
Systemic inflammatory response syndrome in acute‐on‐chronic liver failure: Relevance of ‘golden window’: A prospective study (2017) (44)
The emergence of multidrug-resistant Klebsiella pneumoniae of international clones ST13, ST16, ST35, ST48 and ST101 in a teaching hospital in the Paris region (2012) (44)
Differential inflammasome activation predisposes to acute-on-chronic liver failure in human and experimental cirrhosis with and without previous decompensation (2020) (43)
Hyperkinetic circulatory syndrome in patients with presinusoidal portal hypertension. Effect of propranolol. (1989) (42)
A variant in myeloperoxidase promoter hastens the emergence of hepatocellular carcinoma in patients with HCV-related cirrhosis. (2012) (41)
Vascular nitric oxide production during the development of two experimental models of portal hypertension. (1999) (40)
Cell death markers in cirrhotic patients with acute decompensation (2017) (40)
Glucagon selectively increases splanchnic blood flow in patients with well‐compensated cirrhosis (1988) (40)
Acute-on-Chronic Liver Failure: Recent Concepts. (2015) (39)
Cell death markers in patients with cirrhosis and acute decompensation (2018) (39)
Tezosentan, an endothelin receptor antagonist, limits liver injury in endotoxin challenged cirrhotic rats (2004) (39)
Inhibition of mammalian target of rapamycin aggravates the respiratory burst defect of neutrophils from decompensated patients with cirrhosis (2013) (39)
Systemic Inflammation and Acute-on-Chronic Liver Failure: Too Much, Not Enough (2018) (39)
Aquaretic effects of niravoline, a κ-opioid agonist, in patients with cirrhosis (2000) (38)
Levels and initial course of serum alanine aminotransferase can predict outcome of patients with Budd-Chiari syndrome. (2009) (38)
Blood and plasma 5‐hydroxytryptamine levels in patients with cirrhosis (1994) (38)
Cardiodynamic state is associated with systemic inflammation and fatal acute‐on‐chronic liver failure (2020) (37)
Acute-on-chronic liver failure vs. traditional acute decompensation of cirrhosis. (2018) (37)
Molecular and structural basis of portal hypertension. (2006) (37)
Screening for esophageal varices: Endoscopy, other tools, or endoscopy and other tools? (2008) (36)
Advanced fibrosis: Correlation between pharmacokinetic parameters at dynamic gadoxetate-enhanced MR imaging and hepatocyte organic anion transporter expression in rat liver. (2015) (36)
Risk factors associated with preoperative fecal carriage of extended‐spectrum β‐lactamase‐producing Enterobacteriaceae in liver transplant recipients (2014) (36)
Liver Transplantation for Acute‐on‐Chronic Liver Failure: Science or Fiction? (2020) (36)
Prognostic value of C-reactive protein in cirrhosis: external validation from the CANONIC cohort (2016) (35)
Albumin internalizes and inhibits endosomal TLR signaling in leukocytes from patients with decompensated cirrhosis (2020) (35)
LC3-associated phagocytosis protects against inflammation and liver fibrosis via immunoreceptor inhibitory signaling (2020) (34)
Abnormal pressor response to vasopressin in patients with cirrhosis: Evidence for impaired buffering mechanisms (1990) (34)
Altered control of vascular tone by adenosine triphosphate-sensitive potassium channels in rats with cirrhosis. (1994) (34)
Plasma catecholamine concentrations are a reliable index of sympathetic vascular tone in patients with cirrhosis (1992) (34)
The impact of preoperative hepatic hydrothorax on the outcome of adult liver transplantation (2010) (33)
Acute-on-chronic liver failure: a new syndrome in cirrhosis (2016) (33)
Changes in protein kinase C isoforms in association with vascular hyporeactivity in cirrhotic rat aortas. (2000) (32)
Note of caution: Contaminations of hepatocellular cell lines. (2017) (32)
Liver hypermetabolism during alcohol withdrawal in humans. Role of sympathetic overactivity. (1988) (32)
Role of small-conductance Ca2+-dependent K+ channels in in vitro nitric oxide-mediated aortic hyporeactivity to alpha-adrenergic vasoconstriction in rats with cirrhosis. (2001) (31)
Arterial and mixed venous acid-base status in patients with cirrhosis. Influence of liver failure. (2008) (31)
Effects of oxygen inhalation on tissue oxygenation in patients with cirrhosis. Evidence for an impaired arterial baroreflex control. (1989) (31)
Evidence for an endothelium‐derived hyperpolarizing factor in the superior mesenteric artery from rats with cirrhosis (2000) (31)
Reduction of portal pressure by acute administration of furosemide in patients with alcoholic cirrhosis. (1989) (31)
VEGF-induced angiogenesis drives collateral circulation in portal hypertension. (2005) (30)
Effects of glibenclamide on systemic and splanchnic haemodynamics in conscious rats (1994) (30)
Acute-on-chronic liver failure: A distinct clinical syndrome. (2021) (29)
Cl- absorption across the thick ascending limb is not altered in cystic fibrosis mice. A role for a pseudo-CFTR Cl- channel. (1998) (29)
Meta-analysis of individual patient data of albumin dialysis in acute-on-chronic liver failure: focus on treatment intensity (2019) (29)
Low dose of nitroglycerin failed to improve splanchnic hemodynamics in patients with cirrhosis: Evidence for an impaired cardiopulmonary baroreflex function (1989) (29)
MnSOD Overexpression Prevents Liver Mitochondrial DNA Depletion after an Alcohol Binge but Worsens This Effect after Prolonged Alcohol Consumption in Mice (2011) (29)
G-CSF therapy for severe alcoholic hepatitis: targeting liver regeneration or neutrophil function? (2014) (28)
Targeted lipidomics reveals extensive changes in circulating lipid mediators in patients with acutely decompensated cirrhosis. (2020) (28)
Selective dopamine DA1 stimulation with fenoldopam in cirrhotic patients with ascites: A systemic, splanchnic and renal hemodynamic study (1991) (28)
Intrahepatic cholestasis of pregnancy and acute fatty liver of pregnancy. An unusual but favorable association? (1991) (28)
Development of predisposition, injury, response, organ failure model for predicting acute kidney injury in acute on chronic liver failure (2017) (27)
Impact of cardiac function, refractory ascites and beta blockers on the outcome of patients with cirrhosis listed for liver transplantation. (2020) (27)
Effects of theophylline on hemodynamics and tissue oxygenation in patients with cirrhosis. (1992) (27)
Blockade of ATP-sensitive K+ channels by glibenclamide reduces portal pressure and hyperkinetic circulation in portal hypertensive rats. (1992) (27)
Relationship between portal pressure, esophageal varices, and variceal bleeding on the basis of the stage and cause of cirrhosis. (1997) (27)
Haemodynamic and hormonal responses to long-term inhibition of nitric oxide synthesis in rats with portal hypertension. (1996) (27)
Renal hemodynamics in patients with cirrhosis: relationship with ascites and liver failure. (1993) (26)
Long-term sympathetic and hemodynamic responses to clonidine in patients with cirrhosis and ascites (1992) (26)
[Effects of glypressin on the splanchnic and systemic circulation in patients with cirrhosis]. (1985) (26)
Systemic and splanchnic hemodynamic changes in patients with hepatic schistosomiasis. (2008) (26)
Nitrovasodilators and portal hypertension. (1990) (25)
Acute kidney injury in acute on chronic liver failure (2016) (25)
Trends and the course of liver cirrhosis and its complications in Germany: Nationwide population-based study (2005 to 2018) (2021) (25)
Long-term sympathetic and hemodynamic responses to clonidine in patients with cirrhosis and ascites. (1992) (24)
Hepatocyte microvesicle levels improve prediction of mortality in patients with cirrhosis (2018) (24)
Blunted natriuresis and abnormal systemic hemodynamic responses to C-type and brain natriuretic peptides in rats with cirrhosis. (1995) (24)
[Relationships between plasma concentrations of endothelin and the severity of liver cirrhosis]. (1994) (24)
Impact of cytokine gene variants on the prediction and prognosis of hepatocellular carcinoma in patients with cirrhosis. (2014) (24)
Dose‐dependent effects of a nitric oxide biosynthesis inhibitor on hyperdynamic circulation in two models of portal hypertension in conscious rats (1996) (24)
Plasma endotoxin and tumor necrosis factor-α in the hyperkinetic state of cirrhosis (1995) (24)
Short-term cardiovascular effects of somatostatin in patients with cirrhosis. (2008) (23)
Multifactorial aetiology of hepatic infarction: a case report with literature review (2004) (23)
Assessing the role of amino acids in systemic inflammation and organ failure in patients with ACLF. (2020) (22)
Genetic background of Escherichia coli isolates from patients with spontaneous bacterial peritonitis: relationship with host factors and prognosis. (2008) (22)
Diagnosis and prognosis of acute on chronic liver failure (ACLF) in cirrhosis. (2017) (22)
New clinical and pathophysiological perspectives defining the trajectory of cirrhosis. (2021) (22)
Aquaretic effects of niravoline, a kappa-opioid agonist, in patients with cirrhosis. (2000) (22)
Relationship between hepatic blood flow, liver tests, haemodynamic values and clinical characteristics in patients with chronic liver disease * (1997) (22)
Acute haemodynamic responses and inhibition of tumour necrosis factor-alpha by pentoxifylline in rats with cirrhosis. (1996) (22)
The growing evidence that renal function should be improved in patients with cirrhosis and hepatorenal syndrome before liver transplantation. (2004) (22)
Characterization of Blood Immune Cells in Patients With Decompensated Cirrhosis Including ACLF (2021) (21)
Mitochondrial DNA Maintenance Is Regulated in Human Hepatoma Cells by Glycogen Synthase Kinase 3β and p53 in Response to Tumor Necrosis Factor α (2012) (21)
NADPH oxidase depletion in neutrophils from patients with cirrhosis and restoration via toll-like receptor 7/8 activation (2017) (21)
Acute-on-Chronic Liver Failure: A Distinct Clinical Condition (2016) (21)
Beneficial effects of the 2-day administration of terlipressin in patients with cirrhosis and hepatorenal syndrome (1998) (21)
Low incidence of spontaneous bacterial peritonitis in asymptomatic cirrhotic outpatients. (2013) (21)
Discrepant effects of inducible nitric oxide synthase modulation on systemic and splanchnic endothelial nitric oxide synthase activity and expression in cirrhotic rats (2007) (20)
Abnormal regulation of aortic NOS2 and NOS3 activity and expression from portal vein‐stenosed rats after lipopolysaccharide administration (1999) (20)
Intrahepatic cholestasis of pregnancy and acute fatty liver of pregnancy (1991) (19)
Hemodynamic, metabolic and hormonal responses to oral glibenclamide in patients with cirrhosis receiving glucose. (2001) (19)
Impact of COVID-19 on the liver and on the care of patients with chronic liver disease, hepatobiliary cancer, and liver transplantation: An updated EASL position paper (2022) (19)
Hemodynamics and pharmacokinetics of tezosentan, a dual endothelin receptor antagonist, in patients with cirrhosis (2012) (19)
Lack of prognostic usefulness of hepatic venous pressures and hemodynamic values in a select group of patients with severe alcoholic cirrhosis (2002) (19)
Heme oxygenase: protective enzyme or portal hypertensive molecule? (2001) (19)
Effects of terlipressin on hemodynamics and oxygen content in conscious portal vein stenosed and cirrhotic rats receiving propranolol. (1993) (19)
Microvesicles in hepatic and peripheral vein can predict nonresponse to corticosteroid therapy in severe alcoholic hepatitis (2018) (19)
The role of nitric oxide in the reduction of protein kinase C-induced contractile response in aortae from rats with portal hypertension. (2000) (18)
Relationship between vascular reactivity in vitro and blood flows in rats with cirrhosis. (1999) (18)
Hemodynamic and sympathetic responses to human atrial natriuretic peptide infusion in patients with cirrhosis. (1992) (18)
Relation between severity of liver disease and renal oxygen consumption in patients with cirrhosis (1999) (18)
Transduction of antinatriuretic signals in renal proximal tubular cells in cirrhosis: introduction to novel approaches to the treatment of sodium retention. (1998) (18)
Protein kinase C alterations in aortic vascular smooth muscle cells from rats with cirrhosis. (1998) (17)
Plasma concentrations of cyclic 3′,5′‐guanosine monophosphate in patients with cirrhosis: Relationship with atrial natriuretic peptide and haemodynamics (1997) (17)
Contributing factors and outcomes of burn-associated cholestasis. (2019) (17)
Vascular hyporesponsiveness to vasodilators in rats with cirrhosis. (1997) (17)
Chemokine RANTES Promoter Dimorphisms and Hepatocellular Carcinoma Occurrence in Patients with Alcoholic or Hepatitis C Virus–Related Cirrhosis (2011) (17)
Systemic, splanchnic and renal hemodynamic effects of a dopaminergic dose of dopamine in patients with cirrhosis (1991) (17)
Lack of vascular hyporesponsiveness to the L-type calcium channel activator, Bay K 8644, in rats with cirrhosis. (1995) (17)
Systemic, splanchnic and renal hemodynamic effects of a dopaminergic dose of dopamine in patients with cirrhosis. (1991) (16)
Rapidité d’extraction respective des césariennes et des forceps réalisés en urgence: À propos de 137 extractions pour anomalies du rythme cardiaque fœtal en cours de travail (2005) (16)
Relationships between haemodynamic alterations and the development of ascites or refractory ascites in patients with cirrhosis (2001) (16)
1404 DIAGNOSIS, PREVALENCE, AND PROGNOSIS OF ACUTE-ON- CHRONIC LIVER FAILURE (ACLF): RESULTS OF THE EASL-CHRONIC LIVER FAILURE (CLIF) CONSORTIUM CANONIC STUDY (2012) (16)
Type I interferon signaling in systemic immune cells from patients with alcoholic cirrhosis and its association with outcome. (2017) (15)
Plasma catecholamines in patients with presinusoidal portal hypertension: Comparison with cirrhotic patients and nonportal hypertensive subjects (1991) (15)
Hepatorenal syndrome – definitions and diagnosis (2004) (15)
International Ascites Club Sepsis in cirrhosis: report on the 7th meeting of the (2006) (15)
Protein array technology to investigate cytokine production by monocytes from patients with advanced alcoholic cirrhosis: An ex vivo pilot study (2009) (15)
Oxygen and bile acid content in the azygos blood. Clues to the azygos derivation in patients with portal hypertension. (1987) (15)
Evolution of hypoxemia in patients with severe cirrhosis (2002) (14)
Pre-therapy liver transcriptome landscape in Indian and French patients with severe alcoholic hepatitis and steroid responsiveness (2017) (14)
Detection of bacterial DNA in serum and ascitic fluid of asymptomatic outpatients with cirrhosis and non‐neutrocytic ascites (2011) (14)
Effects of vasopressin on haemodynamics in portal hypertensive rats receiving clonidine. (2008) (14)
Acute Kidney Injury: New Concepts (2008) (14)
Immunodysfunction in Acute-on-Chronic Liver Failure (2018) (13)
Hemodynamic effects of acute administration of furosemide in patients with cirrhosis receiving beta-adrenergic antagonists. (1994) (13)
Complete Deletion of the ramR Gene in an In Vitro-Selected Mutant of Klebsiella pneumoniae Overexpressing the AcrAB Efflux Pump (2012) (13)
Altered growth and lack of responsiveness to angiotensin II in aortic vascular smooth muscle cells from cirrhotic rats. (1997) (13)
Baseline urine metabolic phenotype in patients with severe alcoholic hepatitis and its association with outcome (2018) (12)
Haemodynamic responses to a combination of terlipressin and octreotide in portal hypertensive rats (1997) (12)
Role of Infections in Acute-on-Chronic Liver Failure (2015) (12)
Review article: hepatorenal syndrome--definitions and diagnosis. (2004) (12)
P476 SHORT-TERM (28-DAY) CLINICAL COURSE AND TRANSPLANT-FREE MORTALITY IN ACUTE ON CHRONIC LIVER FAILURE (ACLF); EVIDENCE FOR REVERSIBILITY OF ACLF (A STUDY FROM THE CANONIC DATABASE) (2014) (12)
Molecular epidemiology of Escherichia coli bacteremia in liver transplant recipients (2011) (12)
Are nitric oxide synthases new players in the pathophysiology of fulminant hepatic failure? (2002) (12)
Effects of protein kinase C modulators on Na+/K+ adenosine triphosphatase activity and phosphorylation in aortae from rats with cirrhosis (1998) (12)
[Hemodynamic effects of the administration of terlipressin alone or combined with nitroglycerin in patients with cirrhosis]. (1992) (11)
A French national survey on the use of antibiotic prophylaxis in cirrhotic patients (2013) (11)
New insights in acetaminophen toxicity: HMGB1 contributes by itself to amplify hepatocyte necrosis in vitro through the TLR4-TRIF-RIPK3 axis (2020) (11)
Clearance of atrial natriuretic peptide in patients with cirrhosis. Role of liver failure. (1991) (11)
Plasma exchange for acute on chronic liver failure: is there a light at the end of the tunnel? (2016) (11)
Acute and chronic haemodynamic effects of naftazone in portal hypertensive rats. (1998) (11)
LC3-associated phagocytosis in myeloid cells, a fireman that restrains inflammation and liver fibrosis, via immunoreceptor inhibitory signalling. (2020) (11)
Renal and haemodynamic responses to a novel kappa opioid receptor agonist, niravoline (RU 51,599), in rats with cirrhosis (1996) (11)
Pathogenesis of portal hypertension. (2001) (10)
[Relation between plasma catecholamines, the severity of the liver disease and hemodynamics in patients with cirrhosis]. (1989) (10)
Role of sympathetic cardiovascular tone in control of arterial pressure in rats with cirrhosis. (2008) (10)
Possible mechanisms involved in the discrepancy of hepatic and aortic endothelial nitric oxide synthases during the development of cirrhosis in rats (2009) (10)
Hyponatremia in cirrhosis. Pathophysiology, prevalence, prognostic value, treatment. (2008) (10)
A randomized trial of 6-month norfloxacin therapy in patients with Child-Pugh class C cirrhosis (2017) (10)
Occult gastrointestinal bleeding in high-risk intensive care unit patients receiving antacid prophylaxis: frequency and significance. (1989) (10)
TARGETING CELL-INTRINSIC METABOLISM FOR ANTI-FIBROGENIC THERAPY. (2021) (10)
Clinical course and prognosis of 91 patients with cirrhosis and type 1 hepatorenal syndrome (HRS) treated with terlipressin: a retrospective multicenter study (2001) (10)
Plasma endotoxin and tumor necrosis factor-alpha in the hyperkinetic state of cirrhosis. (1995) (10)
Hemodynamic, neurohumoral, and metabolic responses to amino acid infusion in patients with cirrhosis. (1992) (10)
Tying up PGE2 with albumin to relieve immunosuppression in cirrhosis (2014) (9)
Review of Defective NADPH Oxidase Activity and Myeloperoxidase Release in Neutrophils From Patients With Cirrhosis (2019) (9)
[Tissue hypoxia and hepatocellular insufficiency in patients with cirrhosis]. (1989) (9)
Blunted systemic, splanchnic, and renal hemodynamic responses to atrial natriuretic peptide in rats with cirrhosis. (1994) (9)
Studies of portal hemodynamics and hepatic oxygen consumption during acute liver allograft rejection. (1997) (9)
Le simulateur d'accouchement BirthSIM : un outil complet pour la formation sans risque en obstétrique (2007) (9)
Acute‐on‐Chronic Liver Failure: A New Disease or an Old One Hiding in Plain Sight? (2020) (9)
Viridans group streptococci causing spontaneous bacterial peritonitis and bacteremia in patients with end‐stage liver disease (2008) (9)
Hemodynamic responses to selective blockade of β2- and β1-adrenoceptors in conscious rats with cirrhosis (1994) (9)
Incidence and characteristics of type 2 hepatorenal syndrome in patients with cirrhosis and refractory ascites. (2008) (9)
[Evaluation of the short-term prognosis of cirrhotic patients admitted to intensive care, using 4 scoring systems]. (1985) (9)
Co‐orchestration of acute kidney injury and non‐kidney organ failures in critically ill patients with cirrhosis (2021) (8)
Hepatic Proliferation and Angiogenesis Markers Are Increased after Portal Deprivation in Rats: A Study of Molecular, Histological and Radiological Changes (2015) (8)
Aortic hyporeactivity to norepinephrine induced by lipopolysaccharide in cirrhotic rats: Beneficial effects of a non‐steroidal anti‐inflammatory drug coupled with a nitric oxide donor (2001) (8)
855 DELETERIOUS EFFECTS OF BETA-BLOCKERS ON SURVIVAL AND PARACENTESIS INDUCED CIRCULATORY DYSFUNCTION IN PATIENTS WITH CIRRHOSIS AND REFRACTORY ASCITES (2010) (8)
The role of RIPK1 mediated cell death in acute on chronic liver failure (2021) (8)
Endothelium-dependent blunted membrane potential responses to ATP-sensitive K+ channel modulators in aortae from rats with cirrhosis. (1999) (7)
Naloxone does not alter haemodynamics in cirrhosis. Studies in humans and rats. (1987) (7)
Hépatite fulminante au disulfirame chez un malade atteint de cirrhose alcoolique. Survie après transplantation hépatique. (1989) (7)
Vascular properties of isoflurane: comparison between normal and cirrhotic rats. (1998) (7)
In vitro and in vivo vascular responses to the L‐type calcium channel activator, Bay K 8644, in rats with cirrhosis (1998) (7)
Acute effects of propylthiouracil on hemodynamics and oxygen content in patients with alcoholic cirrhosis. (1997) (7)
Cyclic AMP‐phosphodiesterases inhibitor improves sodium excretion in rats with cirrhosis and ascites (2005) (7)
Pathophysiology of portal hypertension. (1999) (7)
Sepsis in cirrhosis (2013) (7)
Biomarkers of extracellular matrix formation are associated with acute-on-chronic liver failure (2021) (7)
Corrections : Severe sepsis in cirrhosis (Hepatology (2009) 50, (2022-2033) DOI: 10.1002/hep. 23264) (2010) (7)
Untargeted lipidomics uncovers lipid signatures distinguishing severe versus moderate forms of acutely decompensated cirrhosis. (2021) (7)
Marked decreases in protein C and antithrombin III activities in patients with cirrhosis and severe sepsis (2002) (6)
Pulmonary Hemodynamics and Gas Exchange After Liver Transplantation in Patients with Cirrhosis (2002) (6)
Differential blood transcriptome modules predict response to corticosteroid therapy in alcoholic hepatitis (2021) (6)
Hemodynamic and metabolic effects of terlipressin in patients with cirrhosis receiving a nonselective beta-blocker. (1996) (6)
Haemodynamic effects of octreotide in portal hypertensive rats receiving propranolol (1997) (6)
Relationships between plasma atrial natriuretic peptide concentrations and hemodynamics and hematocrit in patients with cirrhosis (1991) (6)
Monoxyde d'azote, vasodilatation et cirrhose: un double (dés)équilibre. (1999) (5)
Corrigendum to "Management of the critically ill patients with cirrhosis: A multidisciplinary perspective". (2016) (5)
Relationship between protein kinase C alterations and nitric oxide overproduction in cirrhotic rat aortas. (2002) (5)
Hemodynamic and metabolic effects of terlipressin in patients with cirrhosis receiving a nonselectiveβ-blocker (1996) (5)
Albumin infusion in spontaneous bacterial peritonitis: another brick off the wall? (2018) (5)
Prevalence of Cardiomyopathy and Impact of the use of Non Selective Beta Blockers in End-Stage Liver Disease (2016) (5)
[Management of patients with cirrhosis and ascites]. (1999) (5)
Acute-on-Chronic Liver Failure. Reply. (2020) (4)
Endotoxemia: an unnecessary but aggravating condition in portal hypertension? (1999) (4)
Corrigendum to “Diagnosis and management of acute kidney injury in patients with cirrhosis: Revised consensus recommendations of the International Club of Ascites” [J Hepatol 2015;62:968–974] (2015) (4)
Bacterial infections in patients with Cirrhosis (2015) (4)
Acute-on Chronic Liver Failure (ACLF): A distinct clinical syndrome (2012) (4)
[Influence of anemia on hemodynamic changes in patients with cirrhosis]. (1997) (4)
Hypertension portale : avancées et perspectives (2009) (4)
Les forceps hier, aujourd'hui et demain. Une nouvelle classification des forceps (2005) (4)
Leukocyte Toll-like receptor 2-mitochondria axis in sepsis: unraveling immune response sophistication. (2014) (4)
Role of pentobarbitone anaesthesia and sympathetic tone in the haemodynamic effects of isosorbide dinitrate in rats with cirrhosis (1996) (3)
Les marabouts de Dori (1964) (3)
Neutralization of lipopolysaccharide effects in liver diseases, the quest for the holy grail (2011) (3)
Acute‐on‐chronic liver failure: Is the definition ready for prime time? (2013) (3)
Responsiveness to growth factors in aortic vascular smooth muscle cells from rats with cirrhosis. (1997) (3)
Influence of transjugular intrahepatic portosystemic shunts (TIPS) on tissue oxygenation in patients with cirrhosis. (2008) (3)
P508 VALIDATION OF THE CLIF-CONSORTIUM (CLIF-C) SCORE TO PREDICT MORTALITY OF PATIENTS WITH ACUTE-ON-CHRONIC LIVER FAILURE (ACLF) IN AN EXTERNAL COHORT AND FOR SEQUENTIAL MEASUREMENTS (2014) (3)
Effect of clonidine on liver oxygen extraction during alcohol withdrawal in man. (1994) (3)
'Eastern type' of Acute-on-chronic Liver Failure (ACLF) is similar in pathophysiologic, diagnostic and prognostic criteria to the 'Western type': A comparison of Chinese hospitalized patients with Hepatitis B with CANONIC data (2014) (3)
The Lipopolysaccharide-Sensing Caspase(s)-4/11 Are Activated in Cirrhosis and Are Causally Associated With Progression to Multi-Organ Injury (2021) (3)
Molecular Mechanisms of Systemic Vasodilation and Hyperdynamic Circulatory State of Cirrhosis (2005) (3)
Prognostic value of C-reactive protein in patients with cirrhosis: external validation from the CANONIC cohort (2014) (3)
Correction to 'Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF' [J Hepatol 2020 (72) 688-701]. (2020) (3)
O74 URINARY NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN (NGAL) IS A STRONG PREDICTOR OF SHORT-TERM OUTCOME IN PATIENTS WITH ACUTE DECOMPENSATION OF CIRRHOSIS. RELATIONSHIP WITH ACUTE-ON-CHRONIC LIVER FAILURE (ACLF) (2014) (3)
[Fulminant hepatitis induced by disulfiram in a patient with alcoholic cirrhosis. Survival after liver transplantation]. (1989) (3)
From the Editor's desk...: July 2016. (2016) (3)
Haemodynamic responses to a ring-deleted analogue of atrial natriuretic peptide in rats with cirrhosis. (2000) (2)
[Hepatorenal syndrome: incidence, predictive factors and prognosis]. (1994) (2)
Erratum to “The CLIF Consortium Acute Decompensation score (CLIF-C ADs) for prognosis of hospitalised cirrhotic patients without acute-on-chronic liver failure” [J Hepatol 2015;62:831–840] (2015) (2)
854 BACTERIAL DNA IS RARELY DETECTED IN THE SERUM AND THE ASCITIC FLUID OF NONINFECTED OUTPATIENTS WITH CIRRHOSIS AND ASCITES TREATED BY PARACENTESIS (2010) (2)
Le sepsis dans la cirrhose (2013) (2)
Profilomètre laser-inertiel (PLI): un essai qualitatif en terrain boisé (1986) (2)
Le pronostic des cirrhoses en réanimation (1985) (2)
Simulateur d'accouchement automatisé BirthSIM pour l'apprentissage sans risque des gestes obstétricaux (2007) (2)
Microcirculatory changes in the liver of patients with refractory ascites and their relationship with diabetes and alcohol (2020) (2)
Bacterial infections in cirrhosis (2015) (2)
Mo1430 - Hepatocyte Release of HMGB1 During Acetaminophen-Induced Liver Injury and Deleterious Feed-Forward Process: Implication of Necroptosis Through TRIF/RIPK3 Axis (2018) (2)
Blocking MAIT cell activation accelerates liver fibrosis regression (2020) (2)
Characterizing a cohort of Egyptian patients with acute-on-chronic liver failure (2021) (2)
Significance of Biliary Phospholipids for Maintenance of the Gastrointestinal Mucosal Barrier and Hepatocellular Integrity (2000) (2)
1414 THE CLIF-CONSORTIUM SCORE PREDICTS MORTALITY MORE ACCURATELY THAN THE MELD AND MELD-SODIUM SCORES IN PATIENTS HOSPITALIZED WITH DECOMPENSATED CIRRHOSIS WITH AND WITHOUT ACUTE-ON-CHRONIC-LIVER FAILURE (ACLF). (2013) (2)
Untargeted lipidomics uncovers lipid signatures that distinguish severe from moderate forms of acutely decompensated cirrhosis ☆ (2021) (2)
Impact of compensated cirrhosis on survival in patients with acute-on-chronic liver failure (2021) (2)
Diagnostic value of fibrosis biochemical markers for the prediction of portal hypertension in chronic liver disease (2003) (2)
1043 PENTOXIFYLLINE (PTX) REDUCES THE RISK OF COMPLICATIONS IN PATIENTS WITH ADVANCED CIRRHOSIS. ANALYSIS OF THE RESULTS OF A PIVOTAL PHASE 3 TRIAL (2009) (2)
Renal Failure in Cirrhosis (2010) (2)
Session 4: Primary Prophylaxis for Variceal Bleeding (2007) (2)
216 BLEEDING IN PATIENTS WITH BUDD-CHIARI SYNDROME (BCS) (2009) (2)
[Treatment of ascites in patients with cirrhosis]. (2001) (2)
543 Multicenter, randomized, controlled, double-blind trial comparing albumin with polygeline for intravascular fluid loading in patients with cirrhosis and ascites (2003) (2)
Reply to: "Acute-on-chronic liver failure - its definition remains unclear". (2013) (2)
Should patients with cirrhosis and variceal hemorrhage receive glucocorticoid therapy? (2015) (2)
THU-036-First description of the immune checkpoint receptor landscape in decompensated cirrhosis and ACLF (2019) (2)
Splanchnic and systemic but not renal hemodynamic responses to atrial natriuretic factor depend on sympathetic outflow changes in cirrhotic patients (1990) (2)
From the Editor's desk....: January 2016. (2016) (2)
Regulation of splanchnic perfusion. (2001) (2)
Les Methodes Topographiques Appliquées à L’Ausculation du Barrage Daniel Johnson (Manicouagan 5) (1972) (1)
Multicenter, randomized, double-blind trial comparing albumin and polygeline for intravascular fluid loading in patients with cirrhosis and tense ascites treated with paracentesis (2004) (1)
Prise en charge de l’ascite réfractaire par l’anastomose portosystémique intrahépatique (TIPS) (2008) (1)
L’ascite réfractaire chez les malades atteints de cirrhose (2008) (1)
Plasma markers of liver cell death Keratin 18 (K18) and its caspase-cleaved fragment (cK18) are novel biomarkers to define progression of cirrhotic patients with acute decompensation to acute on chronic liver failure (ACLF) and mortality (2016) (1)
Urinary MicroARNs as potential biomarkers to predict the evolution of kidney function after liver transplantation in patients with cirrhosis (2017) (1)
Introduction and Survey Results (2016) (1)
Management of the critically ill patients with cirrhosis: A multidisciplinary perspective (vol 64, pg 717, 2016) (2016) (1)
The burden of extended-spectrum β-lactamase-producing Enterobacteriaceae in patients with cirrhosis (2014) (1)
From the editor's desk ... (2015) (1)
Faut-il prévenir l'hypovolémie efficace induite par la paracentèse chez les malades atteints de cirrhose? (2008) (1)
From the Editor’s desk...: January 2018 (2018) (1)
Pre-therapy liver transcriptome landscape in Indian and French patients with severe alcoholic hepatitis and steroid responsiveness (2017) (1)
The hepatic venous pressure gradient (HVPG) in patients with chronic hepatitis C is only associated with the extent of fibrosis and the severity of liver disease (2003) (1)
[Management of refractory ascites with the exception of the transjugular intrahepatic portosystemic shunt (TIPS) and liver transplantation]. (2008) (1)
Systemic inflammation, coagulation disorders and the AD-ACLF syndrome. (2021) (1)
Terlipressin administration decreases iNOS expression and improves circulatory and liver dysfunction in endotoxin-challenged rats with cirrhosis (2001) (1)
282 Diagnostic value of fibrosis biochemical markers (fibrotest) for the prediction of portal hypertension in chronic liver disease (2003) (1)
FRI-111-Albumin modulates endosomal TLR9 signaling in human peripheral leukocytes: A mechanism for its anti-inflammatory role in ACLF (2019) (1)
Gene therapy for Wilson disease : (2015) (1)
[Progress in portal hypertension]. (2009) (1)
Immunosuppression and Increased Risk of Bacterial Infections in Cirrhosis (2021) (1)
Relationship between antiviral therapy responses and hepatic venous pressure gradient changes (2002) (1)
Stimulating hepatocyte renewal: a new paradigm for the treatment of severe alcoholic hepatitis unresponsive to corticosteroids? (2015) (1)
Occult Gastrointestinal Bleeding in High-Risk Intensive Care Unit Patients Receiving Antacid Prophylaxis: Frequency and Significance (1989) (1)
Un savant dérangeant : Jules Marcou (1824-1898), géologue français d'Amérique (1994) (1)
Mitochondrial stress in advanced fibrosis and cirrhosis associated with chronic hepatitis B, chronic hepatitis C, or nonalcoholic steatohepatitis (2022) (1)
Using machine learning for predicting outcomes in ACLF (2022) (1)
Jules Marcou, précurseur français de la géologie nord-américaine (1996) (1)
Prise en charge de l’ascite réfractaire à l’exclusion de l’anastomose portosystémique intrahépatique et de la transplantation hépatique (2008) (1)
Physiopathologie de l’hypertension portale (1995) (1)
From the Editor's desk…From the Editor's desk: September 2016. (2016) (1)
Etiology, time frame and spectrum of decompensation in 6236 patients of cirrhosis liver across Asia: a multinational study from APASL ACLF Research Consortium (AARC) (2017) (1)
Influence of the degree of liver failure on blood volume and its relations to splanchnic and systemic haemodynamics in patients with cirrhosis (1989) (1)
[Effect of the severity of liver disease on renal hemodynamics and renal oxygen consumption in patients with cirrhosis]. (1992) (1)
190 Impaired in vivo responses to endoplasmic reticulum (ER) stress induced by the gram-negative bacteria lipopolysaccharide (LPS) in livers from cirrhotic rats (2006) (1)
Effect of Current Therapies Aimed at Preventing Variceal Rebleeding on Other Complications of Cirrhosis (2016) (1)
Systemic and splanchnic hemodynamic changes in patients with hepatic schistosomiasis (1997) (1)
[Effects of atrial natriuretic factor on renal excretion of sodium in patients with liver cirrhosis]. (1994) (1)
Genetic diversity and virulence profile of Escherichia coli isolates causing spontaneous 1 bacterial peritonitis and bacteremia in patients with cirrhosis 2 3 Running title : Escherichia coli and cirrhosis 4 5 (2010) (1)
Glycogen synthase kianse 3 (GSK3) in immune cells is a major player in TLR4-mediated cytokine storm in patients with advanced cirrhosis (2010) (1)
agonist, in patients (2000) (1)
From the Editor's desk...: June 2018. (2018) (1)
[Indications and role of albumin, plasma volume expansion excluded, in the preoperative or postoperative management of portal hypertension]. (1996) (1)
Correction: The role of RIPK1 mediated cell death in acute on chronic liver failure (2022) (1)
Unrestricted constitutive activity of glycogen synthase kinasde 3 (GSK3) inhibits anti-inflammatory and favors pro-inflammatory cytokine production in LPS-stimulated immune cells from patients with advanced cirrhosis (2009) (1)
[Management of refractory ascites by the transjugular intrahepatic portosystemic shunt (TIPS)]. (2008) (1)
Renal oxygen consumption in patients with cirrhosis (1991) (1)
Diagnosis and management of acute kidney injury in patients with cirrhosis : Revised consensus recommendations of the International Club of Ascites q (2015) (1)
[Renal sympathetic nervous activity in patients with cirrhosis]. (1992) (1)
Prevalence and Short-term Mortality of Acuteon-Chronic Liver Failure (ACLF) in the Veterans Affairs Hospitals (2004-2014): a National US Cohort. (2017) (1)
Acute-on-Chronic Liver Failure (2018) (1)
Physiopathologie et pronostic de lascite rfractaire chez les malades atteints de cirrhose (2008) (1)
Hemodynamic responses to selective blockade of beta 2- and beta 1-adrenoceptors in conscious rats with cirrhosis. (1994) (1)
440 PROGNOSIS OF CRITICALLY ILL CIRRHOTIC PATIENTS UNDERGOING MECHANICAL VENTILATION: IMPLICATIONS FOR THE MANAGEMENT OF ACUTE-ON- CHRONIC LIVER FAILURE (2009) (1)
ÉVALUATION DE L'ENSEIGNEMENT AU PREMIER CYCLE DE L'INSA LYON -- Un chantier de taille, qui demeure ouvert (2015) (0)
Hepatocyte microvesicle levels predict 6-month survival in patients with cirrhosis: results of a prospective study on 242 patients (2017) (0)
From the Editor's desk...: November 2015. (2015) (0)
Reply: (2008) (0)
infections in cirrhosis (2013) (0)
200 Norfloxacin administration reduces aortic nitric oxide synthase (NOSS) upregulation in cirrhotic rats: Role of proinflammatory cytokines and akt signaling pathway (2004) (0)
Thalidomide : an old drug for a new indication ? (2016) (0)
NON-ALCOHOLIC FATTY LIVER DISEASE ( NAFLD ) NGAL as an inflammatory mediator , preserved hemostatic status in NAFLD (2016) (0)
Practice Guidelines EASL clinical practice guidelines on the management of ascites , spontaneous bacterial peritonitis , and hepatorenal syndrome in cirrhosis European Association for the Study of the Liver 1 (2010) (0)
Inhibition of nitric-oxide-mediated vasodilation (including K+ channels) (2004) (0)
640 IN VIVO LIVER ENDOPLASMIC RETICULUM STRESS IN CHRONIC HEPATITIS C (2010) (0)
From the Editor's desk.... : December 2016. (2016) (0)
From the Editor's desk...: December 2015. (2015) (0)
Streamlines in the vicinity of the moving liquid front during the castability test (1995) (0)
Reply to: "Metabolomics to discriminate between acute decompensation and acute-on-chronic liver failure in cirrhosis". (2020) (0)
From the Editor's desk...: June 2016. (2016) (0)
Spontaneous bacterial peritonitis and other infections (2015) (0)
523 HEMODYNAMIC EFFECTS OF TEZOSENTAN, A DUAL ENDOTHELIN RECEPTOR ANTAGONIST, IN PATIENTS WITH CIRRHOSIS (2010) (0)
Crucial role of beta-arrestin-2 in linking fibrogenesis and cancer (2020) (0)
Systemic inflammation is associated with cardiodynamic state in acute-on-chronic liver failure (2020) (0)
Patch-clamp evidence for an alteration of large-conductance Ca2+-activated K+ (KCa) channels in arterial smooth muscle cells (SMC) from rats with cirrhosis (1998) (0)
Intercellular crosstalk regulating ARRB2/RARRES1 is involved in transition from fibrosis to cancer (2021) (0)
From the Editor's desk...: December 2017. (2017) (0)
Big Title: PNPLA3 increases risk of death in alcoholic hepatitis Small title: Carvedilol increases survival of decompensated cirrhosis patients LIVER INJURIES Thymic MAP3K14 and liver homeostasis, deciphering chemotherapy-related liver injuries (CALI) (2017) (0)
Different inflammasome activation predisposes for acute-on-chronic liver failure depending on hepatic compensation in human and experimental liver cirrhosis (2020) (0)
Charni et al. Chemokine RANTES and liver cancer 1 Chemokine RANTES promoter dimorphisms and hepatocellular carcinoma occurrence in patients with alcoholic or HCV-related cirrhosis (2011) (0)
[Nitric oxide, vasodilatation and cirrhosis: a double (dys)equilibrium]. (1999) (0)
Effects Q1 of Albumin Q2 Treatment Q3 on Systemic and Portal Hemodynamics and Systemic In ﬂ ammation in Patients With Decompensated Cirrhosis (2019) (0)
Use of Non-selective Beta-blockers in Decompensated Cirrhosis: Controversy Continues (2016) (0)
Effects of superior mesenteric artery stenosis on splanchnic and systemic hemodynamics in conscious rats with biliary cirrhosis. (1995) (0)
Role of small-conductance calcium-dependent K+ channels in nitric oxide (NO)-mediated aortic hyporeactivity to vasoconstrictors in rats with cirrhosis (2001) (0)
Big title: NAFLD and coronary artery disease Small title (Cirrhosis): Plectin and cholestasis When achieving SVR is futile Antiviral properties of toll-like receptor 7 agonists ACUTE LIVER INJURY Involvement of hepatocyte interleukin (IL)-1 receptor in early lipopolysaccharide (LPS)-induced liver in (2018) (0)
Big title: DAAs reduce post-transplant mortality Cirrhosis (small title): Autoimmune Hepatitis: A familial disease? LIVER INJURY α1-antitrypsin deficiency (A1ATD) induces hepatocyte ER and inflammatory signals, protective role of CARD6 against hepatic ischemia/reperfusion injury A1ATD is an autosoma (2018) (0)
ASSESSMENT OF DOPPLER ECHOCARDIOGRAPHY FOR THE DIAGNOSIS OF PORTOPULMONARY HYERTENSION (PPHT): A PROSPECTIVE STUDY IN 102 CIRRHOTIC PATIENTS AWAITING FOR LIVER TRANSPLANTATION (LT).: Abstract# 782 Poster Board #‐Session: P39‐III (2000) (0)
708 INFLUENCE OF A GENETIC VARIATION IN PNPLA3 ON SUBSEQUENT DEVELOPMENT OF HEPATOCELLULAR CARCINOMA: ANALYSIS OF PROSPECTIVE COHORTS OF PATIENTS WITH ALCOHOLIC OR HCV-RELATED CIRRHOSIS (2012) (0)
Hepatic outflow of catecholamines correlates with systemic but not with splanchnic hemodynamics in patients with cirrhosis (1989) (0)
Subject Index Vol. 28, 2010 (2011) (0)
From the Editor's Desk: January 2019. (2019) (0)
Iconography : Hypertension portale : avancées et perspectives (2009) (0)
Acute-on-Chronic Liver Failure: Pathogenesis and Diagnosis (2011) (0)
Contents Vol. 28, 2010 (2011) (0)
Circulating antibodies to commensal Bacillus subtilis flagellin as a new biomarker for bacterial translocation-driven increased microbe-host interactions in patients with cirrhosis (2010) (0)
P: 44 Non-canonical Inflammasome as a Driver of Hepatic Encephalopathy in a Mouse Model of Acute-on-Chronic Liver Failure (2019) (0)
Severe hyponatremia but not the MELD or MELD-Na scores is an independent predictor of mortality in patients with cirrhosis and refractory as (2011) (0)
Hyponatremia: Pathophysiology, treatment and prognostic value. Summary of the discussion (2008) (0)
Pharmacological evidence that cytochrome P450 is an EDHF-synthase in the superior mesenteric arteries from rats with cirrhosis (2001) (0)
From the Editor's desk... (2017) (0)
Reply to: “Systemic inflammation and disorders of hemostasis in the AD-ACLF syndrome” (2021) (0)
From the Editor's desk…: June 2019. (2019) (0)
From the Editor's desk.…: December 2018. (2018) (0)
From the Editor’s desk...: June 2015 (2015) (0)
[Clinical and Biological Gastroenterology: evaluation of Hepatology division, 1995 to 1997]. (1998) (0)
From the Editor's Desk…: October 2018. (2018) (0)
Kidney inflammation Kidney function Kidney fibrosis Kidney inflammation Kidney function Kidney fibrosis Common bile duct ligation (2017) (0)
M( thodes d'( valuation de I'hypertension portale (1995) (0)
From the Editor's desk…: July 2019. (2019) (0)
External validation of a new equation predicting glomerular filtration rate in patients with cirrhosis candidates for liver transplantation and impaired renal function (2017) (0)
[Pathophysiology and prognosis of refractory ascites in patients with cirrhosis]. (2008) (0)
Development and validation of the CLIF-AD score for the prognosis of patients with acute decompensation of cirrhosis not fulfilling criteria for acute-on-chronic liver failure (ACLF) (2014) (0)
Secondary Prophylaxis in Special Patient Populations (2016) (0)
From the Editor's desk....: August 2018. (2018) (0)
Mucosal-associated invariant T cells are a profibrogenic immune cell population in the liver (2018) (0)
Association between aortic eNOS overactivation and enhanced shear stress in rats with cirrhosis (2001) (0)
Chromatin modifications via histone deacetylation regulate the inflammatory response in lipopolysaccharide (LPS)-stimulated immune cells from patients with advanced cirrhosis (2009) (0)
[Should hypovolemia induced by paracentesis be prevented in patients with cirrhosis?]. (1997) (0)
From the Editor's desk...: November 2016. (2016) (0)
[Role of peripheral arterial vasodilation in the formation of ascites in patients with cirrhosis]. (1993) (0)
From the Editor's Desk…: October 2018. (2018) (0)
[Spontaneous peritonitis: a new indication for intravenous albumin?]. (2000) (0)
194 Upregulation of toll-like receptor 4 (TLR4) is induced by lipopolysaccharide (LPS) to produce enhanced proinflammatory responses in monocytes from patients with cirrhosis (2004) (0)
Effect of a non-steroidal anti-inflammatory drug (NSAID)-no donor (NO) on LPS-induced vascular hyporeactivity and expression of inducible no synthase (NOS II) in cirrhotic rats (1998) (0)
[228] SYSTEMIC HYPERKINETIC STATE: AN INDEPENDENT PREDICTIVE MARKER OF EARLY MORTALITY IN CIRRHOTIC PATIENTS NOT RECEIVING BETA-BLOCKERS (2007) (0)
Recent advances in clinical practice SEPSIS IN CIRRHOSIS : REPORT ON THE 7 TH MEETING OF THE INTERNATIONAL ASCITES CLUB (2005) (0)
Type 1 hepatorenal syndrome in cirrhosis. Predictive factors forsurvival in patients treated with terlipressin (2000) (0)
596 GENE PROFILING REVEALS ABNORMAL INDUCIBILITY OF INFLAMMATORY CYTOKINES AND DEFECTIVE ANTIGEN PROCESSING BY LYSOSOME MHC CLASS II COMPARTMENT IN LPS-STIMULATED IMMUNE CELLS FROM CIRRHOTIC PATIENTS (2012) (0)
Urgent need to increase awareness and screening programs for HCV infection Reliable data about the population-based prevalence of hepatitis C virus (HCV)- (2017) (0)
P0185 : Acute-on-Chronic Liver Failure not associated with bacterial infections. Characteristics, prognosis and importance of systemic inflammatory response (2015) (0)
Soluble immune checkpoints are involved in the immunopathogenesis of ACLF (2020) (0)
83 ALTERED EXPRESSION OF MICRORNAS (MIRNAS) IN LIVERS FROM PATIENTS WITH CHRONIC HEPATITIS C (2009) (0)
From the Editor's desk...: April 2016. (2016) (0)
Corrigendum to "From the Editor's Desk August 2018" [J Hepatol 69 (2018) 265-268]. (2018) (0)
Prospective study of the correlation between the development of liver fibrosis and hemodynamic changes in patients with HCV infection (1998) (0)
Decrease in cardiac work in patients with alcoholic hepatitis: role of inflammation? (2017) (0)
609 LPS INDUCES AN UNEXPECTED ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE (UPRER) IN IMMUNE CELLS FROM PATIENTS WITH CIRRHOSIS (2013) (0)
From the Editor's desk…: August 2019. (2019) (0)
From the Editor’s desk...: July 2015 (2015) (0)
[229] CORRELATION BETWEEN SERUM CREATININE, COCKCROFT FORMULA AND DIRECT MEASUREMENT OF GLOMERULAR FILTRATION RATE IN CANDIDATES FOR LIVER TRANSPLANTATION: IMPLICATIONS FOR MELD SCORE (2007) (0)
Hemodynamics and pharmacokinetics of tezosentan, a dual endothelin receptor antagonist, in patients with cirrhosis (2011) (0)
From the Editor's desk...: May 2017. (2017) (0)
Protocole ameliore pour la paracentese (2001) (0)
Liver transplantation for patients with acute-on-chronic liver failure in Asia (2016) (0)
Prevention of hepatopulmonary syndrome by pentoxifylline in rats with cirrhosis (2003) (0)
[Calculating a severity index and a treatment index. Comparison of cirrhotic and non-cirrhotic patients]. (1984) (0)
Anti-inflammatory and anti-fibrogenic effects of monoacylglycerol lipase inhibitors in the liver involve macrophage autophagy (2018) (0)
Sympathetic nervous activity in patients with presinusoidal portal hypertension (1990) (0)
Contents Vol. 109, 2008 (2008) (0)
Urinary Metabolomic Analysis or Early Prediction of Sepsis in Acute-on -Chronic Liver Failure Patients (2016) (0)
Big Title: Gut-Liver interaction in PSC Small titles: Sarcopenia and fibrosis in NAFLD Trends in global HBV epidemiology Dynamics of HCV replication organelles generation ACUTE LIVER INJURY (2017) (0)
Tezosentan, a dual endothelin receptor antagonist, decreases mortality and liver injury in rats with cirrhosis following endotoxin administration (2002) (0)
Systems Level Analysis for Characterization of Genes Responsible for Outcome in Severe Alcoholic Hepatitis Patients on Steroid Therapy (2016) (0)
Rajiv Jalan at Liver Failure Group, Institute for Liver and Digestive Health, University College London, Royal Free Hospital, UK SELECTION OF THE MONTH Big title: Implementation of four simple interventions can reduce premature alcohol related deaths (2017) (0)
Functional relevance and pro-fibrogenic properties of mucosal-associated invariant T cells (MAIT) during chronic liver diseases (2018) (0)
Deleterious systemic hemodynamic effects of vasopressin in portal hypertensive rats receiving propranolol (1991) (0)
PS-104-Prognosis assessment of acute-on-chronic liver failure in patients with hepatitis B virus-related cirrhosis requires specific criteria (2019) (0)
608 GENE-EXPRESSION PROFILING REVEALS AN UNEXPECTED DEFECT IN INDUCTION OF INTERFERON TARGET GENES IN LPS-STIMULATED IMMUNE CELLS FROM CIRRHOTIC PATIENTS (2013) (0)
Disease-specific treatments (2013) (0)
From the Editor's desk...: August 2016. (2016) (0)
From the Editor's Desk…: October 2019. (2019) (0)
Amino acids (AA) infusion induces renal hyperemia but not hyperfiltration in patients with cirrhosis (1991) (0)
Impaired protein kinase C isoform translocation associated withvascular hyporeactivity in aortae from cirrhotic rats (2000) (0)
A Summary of the Discussions (1987) (0)
Correction: The role of RIPK1 mediated cell death in acute on chronic liver failure (2022) (0)
From the Editor's desk...: May 2016. (2016) (0)
From the Editor's desk…: April 2018. (2019) (0)
From the Editor's desk...: March 2016. (2016) (0)
GENETIC LIVER DISEASES Gene therapy for acute intermittent porphyria (2016) (0)
Prevention of Variceal Rebleeding: Stratifying Risk and Individualizing Care (2016) (0)
746 INTERACTIONS BETWEEN INFECTION, SIRS AND ORGAN FAILURE IN CIRRHOTIC PATIENTS UNDERGOING MECHANICAL VENTILATION (MV) (2009) (0)
Functionnal and mitochondrial dynamics alterations in patients with chronic hepatitis B and advanced fibrosis (2022) (0)
From the Editor's desk.....: February 2017. (2017) (0)
TLR-10 Single Nucleotide Polymorphism is Associated to Poor Short Term Survival in Cirrhotic Patients with Acute on Chronic Liver Failure Precipitated by Bacterial Infections (2016) (0)
111 THE COMBINATION OF GENETIC VARIANTS IN PRO-INFLAMMATORY CYTOKINES PREDICTS THE RISKS OF DEATH AND HEPATOCELLULAR CARCINOMA OCCURRENCE IN PATIENTS WITH HCV-RELATED CIRRHOSIS (2012) (0)
Altered intracellular signal transduction pathways for angiotensin II (Ang II) in cultured aortic smooth muscle clels (ASMCs) from rats with cirrhosis (1995) (0)
The TLR10 polymorphism rs4129009 is associated to poor 28-day survival in patients with cirrhosis and acute on chronic liver failure precipitated by bacterial infection (2016) (0)
P1114 : A metabolomics approach to identify excretory metabolite signature in patients with severe alcoholic hepatitis non responsive to Gluco-Corticosteroid therapy (2015) (0)
Hepatorenal syndrome - definitions and diagnosis. Discussion (2004) (0)
316 IN VIVO ENDOPLASMIC RETICULUM STRESS IN PATIENTS WITH CHRONIC HEPATITIS C (2009) (0)
Sympathetic nervous activation, mitochondrial dysfunction and outcome in acutely decompensated cirrhosis: the metabolomic prognostic models (CLIF-C MET) (2023) (0)
Journal of Hepatology: The Home of Liver Research, 2015-2019. (2019) (0)
A Metabo-Transcriptomics Paired Analysis for Identification of Molecular Mechanisms in Severe Alcoholic Hepatitis non Responsive to Gluco-Corticosteroids Therapy (2016) (0)
From the Editor's desk....: September 2018. (2018) (0)
Severe alcoholic hepatitis as precipitant for organ failure and ACLF. (2022) (0)
Consensus Statements: Preventing Recurrent Variceal Hemorrhage and Other Decompensating Events (2016) (0)
From the Editor's Desk…: December 2019. (2019) (0)
From the Editor's desk....: May 2018. (2018) (0)
From the Editor's desk...: August 2017. (2017) (0)
From the Editor's desk....: April 2017. (2017) (0)
The kynurenine pathway in cirrhosis. Relationship with the development of acute decompensation and acute-on-chronic liver failure, clinical course and mortality (2018) (0)
From the Editor's desk...: September 2017. (2017) (0)
From the Editor’s desk...: September 2015 (2015) (0)
Reply (2010) (0)
From the Editor’s desk…: May 2015 (2015) (0)
Unaltered renal filtration fraction in patients with cirrhosis (1989) (0)
Splanchnic Haemodynamic Investigations (2008) (0)
Stratification based on acute on chronic liver failure (ACLF) has greater prognostic accuracy than stratification based on creatinine, Acute Kidney Injury (AKI), Encephalopathy or Child-Pugh score. Pognostic relevance of 48 hour post-enrolment ACLF stratification (2013) (0)
680 URINARY TLR4: A NOVEL BIOMARKER TO IDENTIFY PATIENTS WITH ACUTE KIDNEY INJURY IN PATIENTS WITH ACUTE ON CHRONIC LIVER FAILURE (2012) (0)
P0426 : Inhibition of monoacylglycerol lipase accelerates liver fibrosis regression (2015) (0)
619 THE MTORC1 INHIBITOR RAPAMYCIN INDUCES A SPECIFIC PRO-INFLAMMATORY PHENOTYPE FAVORING IL-12 IN LPS-STIMULATED IMMUNE CELLS FROM PATIENTS WITH CIRRHOSIS (2011) (0)
From the Editor's desk…: May 2019. (2019) (0)
Severe hyponatremia is the best predictor of mortality in cirrhosis and refractory ascites (2012) (0)
From the Editor's Desk…: November 2019. (2019) (0)
From the Editor's desk...: June 2017. (2017) (0)
Mucosal-associated invariant T cells are functionally impaired during chronic liver diseases and promote fibrosis (2017) (0)
666 ROLE OF HEPATIC CYCLIC AMP IN THE RENAL DYSFUNCTION ASSOCIATED TO THE DEVELOPMENT OF ASCITES IN PATIENTS WITH CIRRHOSIS (2012) (0)
Lack of prognosic usefulness of hepatic pressures and hemodynamic values in patients with alcoholic cirrhosis: a prospective study (1998) (0)
Sympathetic vascular tone in cirrhotic patients (1990) (0)
EASL International Recognition Award Recipient 2015: Prof. Shiv Kumar Sarin. (2015) (0)
Méthodes d’évaluation de l’hypertension portale (1995) (0)
[Are the diagnosis and measurement of portal hypertension of interest?]. (2005) (0)
Identification of new biomarkers of leukocyte dysfunction by lipidomics in patients with acute-on-chronic liver failure (2017) (0)
From the Editor's desk...: May 2017. (2017) (0)
Relationships between plasma atrial natriuretic peptide (ANP) and hematocrit, pulmonary artery and portal pressures in patients with cirrhosis (1991) (0)
From the Editor's desk...: November 2017. (2017) (0)
Variceal Bleeding, Infections and the Hepatorenal Syndrome (2010) (0)
From the Editor's desk....: September 2018. (2018) (0)
Plasma Cystatin C is a predictor of renal failure, hepatorenal syndrome, ACLF and mortality in patients with acutely decompensated liver cirrhosis (2016) (0)
Issues in Trial Design and Areas Needing Further Research (2016) (0)
Role of cytochrome P450 (CYP)-dependent activation of arterialBKCa channels in systemic vasodilation of rats with cirrhosis (2000) (0)
From the Editor's desk...: February 2016. (2016) (0)
From the Editor's Desk: September 2019. (2019) (0)
Lysine acetylation plays a major role in the regulation of the innate TLR4-mediated inflammatory response in patients with cirrhosis (2010) (0)
THU-275-Blood transcript modules differentiate steroid responders from non-responders at baseline in severe alcoholic hepatitis (2019) (0)
Rapamycin enhances the innate Toll-like receptor 4 (TLR4)-dependent pro-inflammatory and angiogenic responses in patients with cirrhosis (2010) (0)
Inhibition of type 4 phosphodiesterase improves sodium excretion incirrhotic rats with ascites (2000) (0)
From the Editor's desk....: April 2018. (2018) (0)
Absorption across the Thick Ascending Limb Is Not Altered in Cystic Fibrosis Mice A Role for a Pseudo-CFTR Cl 2 Channel (1998) (0)
Subject Index Vol. 109, 2008 (2008) (0)
Non-canonical autophagy in myeloid cells constrains hepatic and systemic inflammation and limits fibrosis (2020) (0)
From the Editor's desk....: March 2019. (2019) (0)
Paracentesis‐induced inflammation: a new syndrome? (2014) (0)
From the Editor's desk....: July 2018. (2018) (0)
Responsiveness to growth factors in aortic vascular smooth muscle cells from rats with cirrhosis. (1997) (0)
Renal contribution TC sympathetic overactivity in patients with cirrhosis (1990) (0)
From the Editor's desk...: October 2016. (2016) (0)
P0213 : Diabetes is a major determinant for refractory ascites in patients with cirhosis and is associated with hepatic microcirculatory changes (2015) (0)
From the Editor's Desk…: November 2019. (2019) (0)
Membrane Efﬂux and Inﬂux Modulate both Multidrug Resistance and Virulence of Klebsiella pneumoniae in a Caenorhabditis elegans Model (cid:1) (2010) (0)
[Short and long-term effects of clonidine on sympathetic activity, hemodynamics and renal metabolism of water and sodium in patients with liver cirrhosis]. (1992) (0)
[Refractory ascites in patients with cirrhosis]. (2008) (0)
Interaction between eNOS and iNOS in aortas and superior mesenteric arteries in portal hypertensive rats (2003) (0)
PWE-267 Urinary TLR4: a novel biomarker to identify patients with acute kidney injury in patients with acute on chronic liver failure (2012) (0)
From the Editor's desk...: October 2017. (2017) (0)
From the Editor's desk....: November 2018. (2018) (0)
Defining a ‘golden window' period and relevance of systemic inflammatory response syndrome (SIRS) in acute on chronic liver failure (ACLF) a tool for intervention and improved survival (2015) (0)
Acute-on-chronic liver failure is characterised by hepatocyte gasdermin D cleavage and release of the pro-inflammatory Damage Associated Molecular Pattern (DAMP) IL-α (2018) (0)
From the Editor's desk...: March 2017. (2017) (0)
Proliferative Progenitor Cells in the Colon NOTCH 1 Signaling To Control the Fate of NADPH Oxidase 1 Modulates WNT and (2010) (0)
Organ dysfunctions in patients with alcoholic cirrhosis (2014) (0)
[Influence of ascites on splanchnic and systemic hemodynamics in patients with alcoholic cirrhosis]. (1989) (0)
The prognostic value of the neutrophil-to-lymphocyte ratio in critically ill cirrhotic patients (2021) (0)
α1-Adrenoceptor activation is a prerequisite for octreotide-induced vasoconstriction in the rat superior mesenteric artery (2002) (0)
[Implication of nitrogen oxide producing enzymes in the pathophysiology of fulminant hepatitis]. (2002) (0)
A More Intensive Regimen of Albumin Dyalisis Improves Survival in Patients with Acute on Chronic Liver Failure. Results from an Individual-Patient Data Meta-Analysis (2016) (0)
Defective oxygen utilization by the liver during alcohol withdrawal: Effect of clonidine (1989) (0)
[241] PREDICTIVE FACTORS OF SPONTANEOUS BACTERIAL PERITONITIS IN CIRRHOTIC PATIENT S. RESULTS OF A PROSPECTIVE MULTICENTER STUDY (2007) (0)
Hemodynamic effects of vapreotide, a new somatostatin analogue, in patients with cirrhosis (1998) (0)
Acute Kidney Injury in the Cirrhotic Patient: Unique Features and Challenges (2016) (0)
From the Editor's desk...: March 2018. (2018) (0)
Management of acute critical conditions in hepatology: Mechanisms, consequences and management of infections in liver disease (2010) (0)
HMGB1-driven Feedforward Hepatocyte Necroptosis Circuit in Lethal Acetaminophen-induced liver injury (2015) (0)
New insights in acetaminophen toxicity: HMGB1 contributes by itself to amplify hepatocyte necrosis in vitro through the TLR4-TRIF-RIPK3 axis (2020) (0)
Impact of Treatment of Non-bleeding Complications of Cirrhosis on the Risk of Variceal Bleeding (2016) (0)
Dysfonctions circulatoires de la cirrhose et de l’insuffisance hépatique aiguë sévère (2010) (0)
CA 36-Étude de la valeur pronostique de l’activité rénine plasmatique chez les malades cirrhotiques avec hémorragie digestive par rupture de varices œsophagiennes (2006) (0)
Le diagnostic et la mesure de l'hypertension portale ont-ils un intérêt ? (2005) (0)
Hémorragies digestives hautes chez les malades atteints de cirrhose - II (1997) (0)
A propos d'une truite malade : Etude microbiologique de ses principaux organes et de son environnement (1971) (0)
L'administration de terlipressine prévient la défaillance multi-viscérale induite par l'endotoxine bactérienne chez les rats atteints de cirrhose (2008) (0)
Un projet humain au service de la société comme support d'enseignement de la mécatronique, l'informatique et la productique (2012) (0)
Etude multicentrique, randomisée, en double insu comparant l'albumine humaine et la polygéline pour le remplissage vasculaire chez les malades atteints de cirrhose avec une ascite tendue (2008) (0)
Prophylaxie primaire des infections bactériennes chez les patients cirrhotiques : revue systématique et méta-analyse en réseau (2020) (0)
Utilisation de l’albumine au cours de la cirrhose décompensée : vers de nouveaux concepts (2022) (0)
GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE : BILAN DE LA SECTION HEPATOLOGIE, DE 1995 A 1997 (1998) (0)
Le diabète : un facteur à ne pas sous-estimer au cours de la cirrhose (2012) (0)
C06 - L’administration d’HDL inhibe les mécanismes proinflammatoires hépatiques et restaure l’activité de la no synthase endothéliale dans le foie de rats cirrhotiques ayant reçu du LPS (2005) (0)
Le sepsis dans la cirrhose * Sepsis in cirrhosis (2013) (0)
Doit-on mesurer la concentration plasmatique de « brain natriuretic peptide » chez les malades atteints de cirrhose? (2004) (0)
CO 16 - LE SYNDROME DE RÉPONSE INFLAMMATOIRE SYSTÉMIQUE EST UN FACTEUR PRONOSTIQUE IMPORTANT CHEZ LES MALADES AYANT UNE CIRRHOSE ET UNE INSUFFISANCE RÉNALE (2006) (0)
Le charbon bactéridien (Bacillus anthracis). Son emploi dans l'agression biologique artificielle (2003) (0)
Les microparticules : de nouveaux vecteurs d’information intercellulaire et des biomarqueurs potentiels dans les maladies du foie (2013) (0)
Étude préliminaire de la tolérance au LPS des cellules immunes de malades atteints de cirrhose avancée (2014) (0)
Sur un exemplaire de chat sauvage Felis silvestris brisson capturé dans le département du Doubs (1956) (0)
Décompensation hépatique aiguë chez le malade de réanimation : mécanismes et prévention (2006) (0)
CO 21-L’inhibition de la glycogene synthase kinase3-b (GSK3-B) améliore EX VIVO la réponse inflammatoire au lipopolysaccharide (LPS) dans les monocytes des malades atteints de cirrhose (PRIX LFB 2005) (2006) (0)
L’autophagie au cours des maladies du foie (2011) (0)
C07 - Signalisation de la réponse immunitaire innée induite ex vivo par le lipopolysaccharide et sa modulation par la pentoxifylline dans les monocytes de malades atteints de cirrhose (2005) (0)
Le syndrome hépatorénal (2010) (0)
Algorithme de commande pour la simulation d'accouchements instrumentaux difficiles (2009) (0)
CA 39 - MÉCANISMES DES ALTÉRATIONS DE LA MONOXYDE D'AZOTE « SYNTHASES » ENDOTHÉLIALE (NOSE) HÉPATIQUE ET AORTIQUE CHEZ LE RAT ATTEINT DE CIRRHOSE (2006) (0)
CA 38 - L'ADMINISTRATION D'HDL DIMINUE LE TONUS VASCULAIRE INTRAHÉPATIQUE EN RESTAURANT L'ACTIVITÉ HÉPATIQUE DE LA NO SYNTHASE ENDOTHÉLIALE CHEZ DES RATS ATTEINTS DE CIRRHOSE (2006) (0)
CA - 29Altération de la signalisation intracellulaire en réponse à l’engagement du « toll-like receptor 4 » (TLR4) par le lipopolysaccharide (LPS) dans les monocytes des malades atteints de cirrhose (2004) (0)
Simulation haptique pour l'apprentissage pratique en médecine (2015) (0)
Iconographies supplémentaires de l'article : La surexpression des chimiokines CXC contrôlant la migration des neutrophiles est prédictive du risque de décès chez les patients souffrant de cirrhose décompensée (2015) (0)
Quel est l'impact du shunt intra-hépatique porto-systémique trans-jugulaire (TIPS) sur la survie des malades atteints de cirrhose avec une ascite réfractaire ? (2008) (0)
La voie de l’interféron (IFN)-β est inhibée à plusieurs niveaux dans les cellules immunitaires cirrhotiques (2015) (0)
Anomalies vasculaires des explants hépatiques des malades transplantés pour un syndrome hépatopulmonaire (2008) (0)
Implication des enzymes produisant le monoxyde d'azote dans la physiopathologie de l'hépatite fulminante (2002) (0)
Les mécanismes de la vasodilatation artérielle : exemple de la cirrhose (1997) (0)
Le simulateur automatisé BirthSIM pour la formation des obstétriciens (2011) (0)
Sur la présence d'Utricularia ochroleuca Hartm. dans le Jura (1964) (0)
C016 - Valeur diagnostique d’un nouveau marqueur biochimique (AshTest) pour la prédiction de l’hépatite alcoolique aiguë chez les buveurs excessifs (2005) (0)
Le LPS déclenche une réponse au stress liée à l’accumulation de protéines mal repliées dans le réticulum endoplasmique (RE) dans les cellules immunes de malades cirrhotiques (2013) (0)
Emphysème cervical et pneumomédiastin révélant une perforation colique chez un malade atteint de choc septique (1989) (0)
Déficit d’induction par le LPS des gènes interféron (IFN)-dépendants dans les cellules immunes de malades cirrhotiques (2013) (0)
Effets de la trinitrine sur l'hémodynamique systémique, les pressions sus-hépatiques et l'utilisation de l'oxygène chez les malades atteints de cirrhose (1988) (0)
Physiopathologie de l'hypertension portale au cours de la cirrhose (1998) (0)
Matériaux pour l'étude pédologique et microbiologique des sols alpins. III. Étude d'humus bruts par inoculation de suspensions-dilutions dans les milieux de Lochhead (1968) (0)
Effet de la norfloxacine sur la survie des malades atteints de cirrhose Child-Pugh C : essai contrôlé randomisé avec prise en compte des risques compétitifs (2016) (0)
Identification de facteurs pronostiques délétères dans la cirrhose compliquée d'ascite réfractaire (2012) (0)
Iconography : Rapidité d’extraction respective des césariennes et des forceps réalisés en urgence (2008) (0)
CO 18-Les HDL limitent la surproduction de cytokines pro inflammatoires par les monocytes de malades atteints de cirrhose sévère (2006) (0)
Comparaison de deux indices de gravité 1 chez les malades hépato-gastroentérologiques admis en réanimation (1985) (0)
Contribution à l'étude des tourbières et Hauts-marais jurassiens. I. Remarques sur quelques plantes rares ou critiques (1957) (0)
Sepsis sévère compliquant la cirrhose (2011) (0)
Mesures géodésiques héliportées Théorie et application du nivellement Trigonométrique non-réciproque (1973) (0)
The quest for new therapies in patients with cirrhosis and sepsis. Time to move from the lab to the bedside. (2006) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Richard Moreau?

Richard Moreau is affiliated with the following schools:

Richard Moreau's Academic­Influence.com Rankings

Richard Moreau's Degrees

Similar Degrees You Can Earn

Why Is Richard Moreau Influential?

Richard Moreau's Published Works

Published Works

What Schools Are Affiliated With Richard Moreau?

Richard Moreau's AcademicInfluence.com Rankings